首页 | 本学科首页   官方微博 | 高级检索  
   检索      


Strain selection,medium development and scale-up of toyocamycin production by streptomyces chrestomyceticus
Authors:M C Flickinger PhD  M Greenstein PhD  C Bremmon  J Conlin
Institution:(1) Frederick, Maryland, USA;(2) Institute for Advanced Studies in Biological Process Technology 240 Gortner Laboratories, University of Minnesota, 55108 St. Paul, Minnesota;(3) Lederle Laboratories, American Cyanamid Co., Pearle River, 10965 New York;(4) Pharmaceutical Research and Development Division, Bristol Myers Co., 2404 Pennsylvania Ave., 47721 Evansville, Indiana, USA
Abstract:The batch productivity (Q TM) of the production of the nucleoside antibiotic toyocamycin (TM) by Streptomyces chrestomyceticus was increased ten-fold by selection of a UV generated mutant, optimization of pH, increasing incubation temperature from 28 °C to 36 °C, and addition of soy oil. Initial high oxygen transfer rates stimulated Q TM maxima two-fold. Antibiotic production by the mutant strain, U190, however, appeared more shear sensitive than the parent culture FCRF 341 with maximum antibiotic titer being inversely related to impellor tip velocity, T v . For this reason, scale-up could not be done at constant P/V or constant volumetric oxygen transfer. Instead, programming of impeller speed was evaluated in order to maintain optimal impeller tip velocity during scale-up. It was found that a low constant T v maintained in scale-up in geometrically similar vessels was most beneficial for duplication of optimal antibiotic productivity, Q TM. Pilot fermentations (120 dm3 scale) were used to determine coefficients of Q TM variation from oxygen uptake rate (OUR) and total CO2 evolution data for monitoring of Q TM variation during scale-up to the 12,000 dm3 scale. This technique allowed for on-line prediction of antibiotic titer and Q TM from fermentor exhaust gas data.List of Symbols A scale constant - B shape constant - C location of maximum constant - D m impeller diameter (m) - H m liquid height (m) - OTR MmolO2·(dm3)–1min–1 oxygen transfer rate - OUR MmolO2·(dm3)–1min–1 oxygen uptake rate - PCV cm3 packed cell volume - P/V watts/dm3 volumetric power consumption - Q 1 · min–1 corrected to standard conditions of temperature, pressure aeration rate - Q TM mgrg/(cm3 · h) or kg/(m3 · h) antibiotic productivity - T m tank diameter - T mix s mixing time - T v cm · s–1 impeller tip velocity - TM mgrg/cm3 Toyocamycin concentration - TNP Tricyclic nucleoside phosphate
Keywords:
本文献已被 SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号